Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Gerresheimer AG's share price for the quarter that ended in Feb. 2024 was $30. Gerresheimer AG's Shares Outstanding (EOP) for the quarter that ended in Feb. 2024 was 138 Mil. Therefore, Gerresheimer AG's market cap for the quarter that ended in Feb. 2024 was $4,145 Mil.
Gerresheimer AG's quarterly market cap
increased
from Aug. 2023 ($2,595 Mil) to Nov. 2023 ($3,454 Mil) and
increased
from Nov. 2023 ($3,454 Mil) to Feb. 2024 ($4,145 Mil).
Gerresheimer AG's annual market cap
stayed the same
from Nov. 2021 ($0 Mil) to Nov. 2022 ($0 Mil) but then
increased
from Nov. 2022 ($0 Mil) to Nov. 2023 ($3,454 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Gerresheimer AG's Enterprise Value for Today is $4,870 Mil.
Gerresheimer AG Market Cap Historical Data
The historical data trend for Gerresheimer AG's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Gerresheimer AG's Market Cap
For the Medical Instruments & Supplies subindustry, Gerresheimer AG's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gerresheimer AG's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's Market Cap distribution charts can be found below:
* The bar in red indicates where Gerresheimer AG's Market Cap falls into.
Gerresheimer AG Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Gerresheimer AG's Market Cap for the fiscal year that ended in Nov. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gerresheimer AG (OTCPK:GRRMY) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Gerresheimer AG Market Cap Related Terms
Thank you for viewing the detailed overview of Gerresheimer AG's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Gerresheimer AG (Gerresheimer AG) Business Description
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GRRMY has been successfully added to your 